Search

everythinglearnresearchcommunity

for

Search:↓

A Brazilian teenager with severe hair loss had total hair regrowth with no side effects after using tofacitinib.

Leflunomide and anthralin may effectively treat severe alopecia areata.

JAK inhibitors may help treat Alopecia Areata but need careful monitoring due to side effects.

The conditions alopecia areata, primary sclerosing cholangitis, and ulcerative colitis may be linked by shared autoimmune and cell death mechanisms.

Treating alopecia areata every 3 weeks with diphenylcyclopropenone is more effective than weekly treatments.

Baricitinib and deuruxolitinib are effective for treating alopecia areata, but their efficacy depends on the dose.

New targeted therapies for hair loss from alopecia areata show promise, with personalized treatment expected in the future.

Rare changes in the KRT82 gene are linked to a higher risk of Alopecia Areata.

Tofacitinib improves nail conditions in patients with severe hair loss and does not affect hair regrowth.

Alopecia areata needs new treatments targeting autoimmune processes due to its emotional impact and variable treatment responses.

Current research explores hair growth drugs, while future research aims for personalized treatments.

Herbs might help with hair loss, but more research is needed to confirm their safety and effectiveness.

The AIRE gene variant rs2075876 is linked to a higher risk of alopecia areata in males.

Nonsteroid treatments for alopecia areata show promise but need more high-quality research.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.

Oral baricitinib and ruxolitinib are effective and safe for treating alopecia areata.

Both dermatologists and patients in Japan agree that treatment success for alopecia areata is having 20% or less scalp hair loss.

A mix of tocopherol acetate and L-menthol helps grow hair better than using them separately or using minoxidil.

People with Alopecia Areata often have lower vitamin D levels, and vitamin D supplements might help treat it.

Interleukin-6 may play a role in causing alopecia areata.

Beard hair loss can signal early diabetes and thyroid issues, treatable with specific cream.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

JAK inhibitors help hair regrowth but not fully effective for androgenetic alopecia.

CD2 might be a new treatment target for patchy alopecia areata.

Restoring immune privilege in hair follicles could help treat certain types of hair loss.

Poor response to topical immunotherapy in alopecia areata patients is linked to impaired cell responses.

Oral JAK inhibitors are safe for alopecia areata, but baricitinib may cause more acne and infections.

Researchers found four genes that could help diagnose severe alopecia areata early.

ILC1 cells contribute to hair loss in alopecia areata.

Tofacitinib, a JAK inhibitor, improved hair regrowth in most patients with severe alopecia areata and had minimal side effects.